Recombinant Human GDAP1 Protein，GST

GDAP1 (Ganglioside-induced differentiation-associated protein 1) is a member of the mitochondrial protein family implicated in the regulation of mitochondrial dynamics, including fission and fusion processes. It plays a critical role in neuronal health, and mutations in the GDAP1 gene have been linked to several neurodegenerative disorders, particularly Charcot-Marie-Tooth disease (CMT), a hereditary neuropathy characterized by muscle weakness and atrophy. Research into GDAP1 has gained momentum due to its potential as a biomarker for these diseases and a target for therapeutic interventions. The recombinant expression of GDAP1 offers insights into its biological functions and interactions within the mitochondria, facilitating a deeper understanding of the molecular mechanisms underlying mitochondrial pathology. By producing GDAP1 as a recombinant protein, researchers can analyze its structure-function relationship, assess how mutations affect its behavior, and explore its role in mitochondrial defects. This approach not only enhances our comprehension of GDAP1’s contribution to neuronal integrity but also paves the way for developing targeted therapies aimed at mitigating the effects of GDAP1-related neuropathies. Overall, GDAP1 research underscores the intricate relationship between mitochondrial dynamics and neurodegenerative diseases, highlighting the need for continued exploration into its functional properties and the therapeutic possibilities they may offer.